INS and endothelial dysfunction: In conclusion, the modifications observed overtime after sunitinib treatment in terms of markers of early endothelial dysfunction, blood pressure, as well as in glucose/insulin metabolism and proteinuria might increase the cardiovascular risk in RCC patients treated with sunitinib.